B
Last Price
52 Week Range
- - -
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | TRY8.35B |
EV | TRY13.33B |
Shares Outstanding | 500.00M |
Beta | 0.07 |
Industry | - |
Analyst Rating | BUY |
Analyst Target Price | |
Number of Analysts | 1 |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | 2.43% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Biotrend Cevre ve Enerji Yatirimlari A.S.
BIOEN
Sector
Industry
CEO
Eroglu, Ozgur
Employees
707
Website
www.biotrendenerji.com.trIPO Date
Headquarters
Ekinciler Caddesi, Erturk Sokak 3, Kavacik Beykoz, Istanbul 34810, Turkey
Biotrend Cevre ve Enerji Yatirimlari (BIOEN) is considered a low volatility stock. It has a beta of 0.07, which means it typically moves 0.07 times as much as the broader market. Last updated: December 31, 2025 at 11:46 PM Eastern Time
Based on current BIOEN analyst forecasts and market assumptions, the consensus price target for Biotrend Cevre ve Enerji Yatirimlari (BIOEN) is TRY24.20 for 2027. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated:
The current Biotrend Cevre ve Enerji Yatirimlari (BIOEN) market capitalization is approximately TRY8.35B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Biotrend Cevre ve Enerji Yatirimlari's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:46 PM Eastern Time
In the most recently reported quarter, Biotrend Cevre ve Enerji Yatirimlari (BIOEN) generated TRY679.05M in revenue, representing a +16.25% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:35 AM Eastern Time
In the most recently reported fiscal year, Biotrend Cevre ve Enerji Yatirimlari (BIOEN) generated net income of TRY98.60M, compared with TRY948.12M in the prior fiscal year, representing a -89.60% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:35 AM Eastern Time
According to its latest quarterly filing, Biotrend Cevre ve Enerji Yatirimlari (BIOEN) reported EBITDA of TRY83.79M, representing a +13.91% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 2:35 AM Eastern Time
As of the most recent reporting period, the company's debt-to-equity ratio stands at 1.16x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 2:35 AM Eastern Time
In the most recently reported quarter, Biotrend Cevre ve Enerji Yatirimlari (BIOEN) revenue was TRY679.05M. Earnings per share (EPS) for the quarter were TRY-0.26. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:35 AM Eastern Time
Biotrend Cevre ve Enerji Yatirimlari (BIOEN) does not currently pay a dividend. Over the last twelve months (LTM), the company paid TRY0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 2:35 AM Eastern Time
Analyst assessments of whether Biotrend Cevre ve Enerji Yatirimlari (BIOEN) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Consensus price target: TRY24.20 An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated:
Based on the latest available analyst coverage, Biotrend Cevre ve Enerji Yatirimlari (BIOEN) currently carries a Buy consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated:
Like other publicly traded stocks, Biotrend Cevre ve Enerji Yatirimlari (BIOEN) shares are bought and sold on stock exchanges such as IBSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Biotrend Cevre ve Enerji Yatirimlari (BIOEN) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add BIOEN to your watchlist.
Biotrend Cevre ve Enerji Yatirimlari trades under the ticker symbol BIOEN on the IBSE stock exchange. The ticker BIOEN is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Biotrend Cevre ve Enerji Yatirimlari (BIOEN) employs approximately 707 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:46 PM Eastern Time
Biotrend Cevre ve Enerji Yatirimlari (BIOEN) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Biotrend Cevre ve Enerji Yatirimlari (BIOEN) stock peers based on overlapping products, services, and competitive dynamics:Ellomay Capital (ELLO)Birlesim Grup Enerji Yatirimlari (BIGEN)China Ruifeng Renewable Energy Holdings (527)Consus Enerji Isletmeciligi ve Hizmetleri (CONSE)Henan BCCY Environmental Energy (300614)Hun Yenilenebilir Enerji Üretim (HUNER) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Biotrend Cevre ve Enerji Yatirimlari.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.